Metabolic syndrome (MetS) is a clinical construct that conglomerates risk factors interconnected with cardiovascular diseases and type 2 diabetes. More than a thousand million individuals in the world were diagnosed with MetS in 2018.
Objective:
Our objective was to examine the prevalence of MetS and its components among Mexican adults.
Methods:
Data from 1733 adults aged ≥20 years who participated in the Mexican National Health and Nutrition Survey 2021. Sociodemographic, and clinical factors were gathered and analyzed. To define MetS, we used the harmonized diagnosis criteria.
Results:
The prevalence of MetS in Mexican adults was 45.3% (43.7% in men and 46.8% in women). This was mainly driven by increased abdominal obesity (AO) 79.8% and dyslipidemia (low high-density lipoprotein [HDL]-cholesterol and hypertriglyceridemia) 77.1%. The proportion of subjects with a least one MetS component was 90.5% and with any combination of two components was 25.2% and for three was 28.9%. The most frequent combination of MetS components was the cluster of AO, low HDL-cholesterol, and hypertriglyceridemia (15.6%).
Conclusions:
A high prevalence of MetS was registered in Mexico in 2021. Women and adults aged 40 years or older were the groups with the highest prevalence of MetS and its components. The health system in Mexico must promote strategies for the prevention and control of MetS and its components in adults.
Get full access to this article
View all access options for this article.
References
1.
KendallDM, HarmelAP. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: Understanding the role of insulin resistance. Am J Manag Care, 2002; 8(20 Suppl):S635–S53.
2.
AlbertiKG, EckelRH, GrundySM, et al.; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the study of obesity. Circulation, 2009; 120(16):1640–1645; doi: 10.1161/CIRCULATIONAHA.109.192644
3.
SaklayenMG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep, 2018; 20(2):12; doi: 10.1007/s11906-018-0812-z
4.
Rojas-MartínezR, Aguilar-SalinasCA, Romero-MartínezM, et al.Trends in the prevalence of metabolic syndrome and its components in Mexican adults, 2006-2018. Salud Publica Mex, 2021; 63(6):713–724; doi: 10.2114/9/12835
5.
KukJL, ArdernCI. Age and sex differences in the clustering of metabolic syndrome factors: Association with mortality risk. Diabetes Care, 2010; 33(11):2457–2461; doi: 10.2337/dc10-0942
6.
YamaokaK, TangoT. Effects of lifestyle modification on metabolic syndrome: A systematic review and meta-analysis. BMC Med, 2012; 10:138; doi: 10.1186/1741-7015-10-138
7.
BankoskiA, HarrisTB, McClainJJ, et al.Sedentary activity associated with metabolic syndrome independent of physical activity. Diabetes Care, 2011; 34(2):497–503; doi: 10.2337/dc10-0987
8.
KimCE, ShinS, LeeHW, et al.Association between sleep duration and metabolic syndrome: A cross-sectional study. BMC Public Health, 2018; 18(1):720; doi: 10.1186/s12889-018-5557-8
9.
SunK, LiuJ, NingG. Active smoking and risk of metabolic syndrome: A meta-analysis of prospective studies. PLoS One, 2012; 7(10):e47791; doi: 10.1371/journal.pone.0047791
10.
AlkerwiA, BoutsenM, VaillantM, et al.Alcohol consumption and the prevalence of metabolic syndrome: A meta-analysis of observational studies. Atherosclerosis, 2009; 204(2):624–635; doi: 10.1016/j.atherosclerosis.2008.10.036
11.
Den Engelsen. D: Screening for Metabolic Syndrome in Primary Care. Utrecht University: Netherlands; 2012.
12.
Cabrera-PivaralCE, Gutierrez-RuvalcabaCL, Peralta-HerediaIC, et al.Development and validation of an instrument to measure family physicians’ clinical aptitude in metabolic syndrome in Mexico. Salud Publica Mex, 2008; 50(6):457–462; doi: 10.1590/s0036-36342008000600006
13.
FordES, LiC, SattarN. Metabolic syndrome and incident diabetes: Current state of the evidence. Diabetes Care, 2008; 31(9):1898–1904; doi: 10.2337/dc08-0423
14.
GamiAS, WittBJ, HowardDE, et al.Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol, 2007; 49(4):403–414; doi: 10.1016/j.jacc.2006.09.032
15.
BarqueraS, Pedroza-TobiasA, MedinaC, et al.Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res., 2015; 46(5):328–338; doi: 10.1016/j.arcmed.2015.06.006
16.
BarqueraS, Pedroza-TobiasA, MedinaC. Cardiovascular diseases in mega-countries: The challenges of the nutrition, physical activity and epidemiologic transitions, and the double burden of disease. Curr Opin Lipidol., 2016; 27(4):329–344; doi: 10.1097/MOL.0000000000000320
17.
LiawFY, KaoTW, WuLW, et al.Components of metabolic syndrome and the risk of disability among the elderly population. Sci Rep, 2016; 6:22750; doi: 10.1038/srep22750
18.
ArdernCI, JanssenI. Metabolic syndrome and its association with morbidity and mortality. Appl Physiol Nutr Metab, 2007, 32(1):33–45; doi: 10.1139/h06-099
19.
Romero-MartínezM, Barrientos-GutiérrezT, Cuevas-NasuL, et al.National health and nutrition survey 2021 methodology. Salud Publica Mex, 2021; 63(6):813–818; doi: 10.2114/9/13348.20
20.
WHO: World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854 World Health Organization. Geneva; 1995.
21.
WHO: Physical status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. World Health Organization: Geneva; 1995.
22.
PickeringTG, HallJE, AppelLJ, et al.Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the subcommittee of professional and public education of the American heart association council on high blood pressure research. Circulation., 2005; 111(5):697–716; doi: 10.1161/01
23.
LeveyAS, StevensLA, SchmidCH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med, 2009; 150(9):604–612; doi: 10.7326/0003-4819-150-9-200905050-00006
24.
Romero-MartínezM, Barrientos-GutiérrezT, Cuevas-NasuL, et al.Metodología de la encuesta nacional de salud y nutrición 2022 y planeación y diseño de la ensanut continua 2020-2024. Salud Publica Mex, 2022; 64(5):522–529.
25.
Rojas-MartínezR, Aguilar-SalinasCA, Jiménez-CoronaA. Optimal cutoff points for the detection of undiagnosed type 2 diabetes, hypertension and metabolic syndrome in Mexican adults. Salud Pub Mex, 2012; 54:13–19.
26.
NoubiapJJ, NansseuJR, Lontchi-YimagouE, et al.Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract, 2022; 188:109924; doi: 10.1016/j.diabres.2022.109924.26
27.
Gaona-PinedaEB, Martinez-TapiaB, Arango-AngaritaA, et al.Food groups consumption and sociodemographic characteristics in Mexican population. Salud Publica Mex, 2018; 60(3):272–282; doi: 10.2114/9/8803
28.
RippeJM, AngelopoulosTJ. Relationship between added sugars consumption and chronic disease risk factors: Current understanding. Nutrients, 2016; 8(11); doi: 10.3390/nu8110697
29.
AburtoTC, PedrazaLS, Sanchez-PimientaTG, et al.Discretionary foods have a high contribution and fruit, vegetables, and legumes have a low contribution to the total energy intake of the Mexican population. J Nutr, 2016; 146(9):1881S–1887S; doi: 10.3945/jn.115.219121
30.
Mendoza-HerreraK, Pedroza-TobiasA, Hernandez-AlcarazC, et al.Attributable burden and expenditure of cardiovascular diseases and associated risk factors in Mexico and other selected mega-countries. Int J Environ Res Public Health, 2019; 16(20):4041; doi: 10.3390/ijerph16204041
31.
HaslamDE, PelosoGM, HermanMA, et al.Beverage consumption and longitudinal changes in lipoprotein concentrations and incident dyslipidemia in US adults: The framingham heart study. J Am Heart Assoc, 2020; 9(5):e01408; doi: 10.1161/JAHA.119.014083
32.
PradhanAD. Sex differences in the metabolic syndrome: Implications for cardiovascular health in women. Clin Chem, 2014; 60(1):44–52; doi: 10.1373/clinchem.2013.202549
33.
PucciG, AlcidiR, TapL, et al.Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol Res, 2017; 120:34–42; doi: 10.1016/j.phrs.2017.03.008
34.
BarqueraS, Hernández-BarreraL, Oviedo-SolísC, et al.Obesity in adults. Salud Publica Mex, 2024; 66(4, jul-ago):414–424; doi: 10.2114/9/15863
35.
MedinaC, JáureguiA, HernándezC, et al.Prevalence of movement behaviors in Mexico. Salud Publica Mex, 2023; 65(supl 1):S259–S267; doi: 10.2114/9/14754
36.
StephensCR, EastonJF, Robles-CabreraA, et al.The impact of education and age on metabolic disorders. Front Public Health, 2020; 8:180; doi: 10.3389/fpubh.2020.00180
37.
DhondgeRH, AgrawalS, PatilR, et al.A comprehensive review of metabolic syndrome and its role in cardiovascular disease and type 2 diabetes mellitus: Mechanisms, risk factors, and management. Cureus, 2024; 16(8):e67428; doi: 10.7759/cureus.67428
38.
ZaliūnasR, SlapikasR, BabarskieneR, et al.The prevalence of the metabolic syndrome components and their combinations in men and women with acute ischemic syndromes. Medicina (Kaunas), 2008; 44(7):521–528.
39.
PimentaAM, Felisbino-MendesMS, Velasquez-MelendezG. Clustering and combining pattern of metabolic syndrome components in a rural Brazilian adult population. Sao Paulo Med J, 2013; 131(4):213–219; doi: 10.1590/1516-3180.2013.1314326
